EMUGEN
Pharmaceutical and biological preparations, namely, gene therapy products for the treatment of Rett Syndrome, Dravet Syndrome, neurological diseases and disorders, central nervous system disease and disorders, and genetic diseases and disorders; Pharmaceutical preparations for gene replacement and gene regulation in diseases, disorders, and conditions affecting the brain and central nervous system; Drug delivery agents, namely, bioengineered adeno-associated virus vectors for delivering gene ...
Pending · March 31, 2026 · 99735877 ·